Apimeds Pharmaceuticals US, Inc. (APUS) market cap is $2.4M
Apimeds Pharmaceuticals US, Inc. (APUS) market cap is $2.4M. That figure is from Lician’s product cache for this healthcare name — not a placeholder and not copied across tickers.
Read the full APUS research page for quote, filings, and the rest of the model. This satellite exists so “Apimeds Pharmaceuticals US, Inc. market cap” can rank with the actual number, then send you to /stock/apus.